ArQule, Inc.
NASDAQ:ARQL
$5.87
$0.05
(0.86%)
Related Resources
ARQL
vs. S&P 500
|
$5.87
$0.05
(0.86%)
|
|
| Today's Open | $5.81 |
|---|---|
| Previous Close | $5.82 |
| Daily Range | $5.79 - $5.89 |
| 52-Week Range | $3.98 - $8.32 |
| Market Cap | $365.1M |
| P/E Ratio | -23.28 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 315,528 |
| Average Daily Volume | 518,617 |
| Current FY EPS | -$0.32 |
Sector
Healthcare
Industry
Biotechnology
Description
A clinical-stage biotechnology company, engaged in the research and development of cancer therapeutics. Its mission is to research, develop and commercialize targeted cancer drugs with reduced toxicities compared to conventional cancer chemotherapeutics.
